PRNewswire

Financing led by Novo Holdings, RA Capital Management, Royalty Pharma, SR One, and TPG Life Sciences Innovations, with participation from 16 additional new and existing investors Proceeds will be used, in part, to establish Ph3 and commercial-scale GMP manufacturing capacity that will accelerate cli

LOS ANGELES, Oct. 31, 2024 /PRNewswire/ — Cove Capital Investments, LLC, a Delaware Statutory Trust sponsor company, announced it has successfully completed the purchase of an Industrial Asset in Athens, GA. The purchase is the firm’s General Time Industrial Park Opportunity 84 DST, a Re

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: